Cargando…

Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients

To examine the influences of bevacizumab combined with intensity-modulated radiation therapy (IMRT) on postoperative brain glioma, particularly its impact on coagulation function and cognitive function, the complete clinical data of 156 patients undergoing glioma surgery in the neurosurgery departme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Guo-Shi, Wang, Wei-Wei, Lin, Hong, Lin, Rui-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934211/ https://www.ncbi.nlm.nih.gov/pubmed/35313514 http://dx.doi.org/10.1155/2022/9367919

Ejemplares similares

Retracted: Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
por: Healthcare Engineering, Journal of
Publicado: (2023)

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
por: Hattori, Yasuhiko, et al.
Publicado: (2022)

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial
por: Cohen, Adam L., et al.
Publicado: (2020)

Clinical efficacy of early postoperative intensity-modulated radiotherapy combined with Temozolomide chemotherapy in the treatment of patients with malignant glioma
por: Zhou, Hongyang, et al.
Publicado: (2022)

Postoperative Intensity-Modulated Radiation Therapy for Myoepithelial Carcinoma in the Parotid Gland
por: Nakatsu, Kanako, et al.
Publicado: (2022)

Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer
por: Zhao, Yaqin, et al.
Publicado: (2015)

The Impact of Reduced-Volume, Intensity-Modulated Radiation Therapy on Disease Control in Nasopharyngeal Carcinoma
por: Lin, Yu-Wei, et al.
Publicado: (2015)

Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
por: Sun, Mao, et al.
Publicado: (2023)

Bevacizumab combined with re-irradiation in recurrent glioblastoma
por: She, Lei, et al.
Publicado: (2022)

The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)
por: Zhong, Qiulu, et al.
Publicado: (2023)

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
por: Cha, Yongjun, et al.
Publicado: (2017)

ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma
por: Shi, Ying, et al.
Publicado: (2021)

Influences of dexmedetomidine on stress responses and postoperative cognitive and coagulation functions in patients undergoing radical gastrectomy under general anesthesia
por: Ma, Xiang-Fei, et al.
Publicado: (2023)

A Single Institution’s Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma
por: Mayer, Tina, et al.
Publicado: (2008)

Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab
por: Blesa, Joan Manel Gasent, et al.
Publicado: (2012)

A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan
por: Murakami, Naoya, et al.
Publicado: (2015)

Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients
por: Yoon, Han Gyul, et al.
Publicado: (2021)

Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma()()
por: Wang, Jin, et al.
Publicado: (2015)

Postoperative Cognitive Dysfunction after Coronary Artery Bypass Grafting
por: Yuan, Shi-Min, et al.
Publicado: (2019)

Enhancement of radiation response with bevacizumab
por: Hoang, Tien, et al.
Publicado: (2012)

An exploratory clinical trial of apatinib combined with intensity‐modulated radiation therapy for patients with unresectable hepatocellular carcinoma
por: Qiu, Hu, et al.
Publicado: (2022)

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy
por: Peng, Hao, et al.
Publicado: (2016)

Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison
por: Wang, Lei, et al.
Publicado: (2019)

Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study
por: Wang, Kang, et al.
Publicado: (2023)

Comparison of Dosimetric Gains Provided by Intensity-Modulated Radiotherapy, Volume-Modulated Arc Therapy, and Helical Tomotherapy for High-Grade Glioma
por: Liu, Pei, et al.
Publicado: (2020)

Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma
por: Mi, Jing-Lin, et al.
Publicado: (2021)

Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion()()
por: Ishida, Joji, et al.
Publicado: (2014)

Delivery of bevacizumab by intracranial injection: assessment in glioma model
por: Liu, Yu-Xiao, et al.
Publicado: (2018)

Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications
por: Li, Yi, et al.
Publicado: (2017)

Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023)

Choroidal metastasis: Radiation and bevacizumab at presentation
por: Maheshwari, Abhilasha, et al.
Publicado: (2023)

Intensity-Modulated Radiation Therapy
por: Webb, S
Publicado: (2001)

Intensity modulated radiation therapy versus three‐dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison
por: MacDonald, Shannon M., et al.
Publicado: (2007)

Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei
por: Zhang, Ying, et al.
Publicado: (2023)

Successful therapy with bevacizumab combined with corticosteroids for crizotinib-induced interstitial lung disease
por: Xie, Xiaohong, et al.
Publicado: (2019)

The Effect on Quality of Life after Three-Dimensional Intensity-Modulated Radiation Therapy in Patients with Low-Grade Glioma
por: Chen, Huili, et al.
Publicado: (2022)

Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
por: Kulinich, Daniel P., et al.
Publicado: (2021)

Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer
por: Hsieh, Chen-Hsi, et al.
Publicado: (2011)

Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era
por: Yang, Xing‐Li, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9sqcip77ac2lqqrlob6m1b98at